Bohan D; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America. Van Ert H; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America. Ruggio N; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America. Rogers KJ; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America. Badreddine M; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America. Aguilar Briseño JA; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America. Elliff JM; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America. Rojas Chavez RA; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America. Gao B; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. Stokowy T; Department of Biomedicine, University of Bergen, Bergen, Norway. Christakou E; Department of Biomedicine, University of Bergen, Bergen, Norway.; BerGenBio ASA, Bergen, Norway. Kursula P; Department of Biomedicine, University of Bergen, Bergen, Norway.; Biocenter Oulu & Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland. Micklem D; BerGenBio ASA, Bergen, Norway. Gausdal G; BerGenBio ASA, Bergen, Norway. Haim H; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America. Minna J; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. LorensJB; Department of Biomedicine, University of Bergen, Bergen, Norway. Maury W; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2021 Nov 19; Vol. 17 (11), pp. e1009743. Date of Electronic Publication: 2021 Nov 19 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cancer Cells.
Autorzy:
Dyrstad SE; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway. Lotsberg ML; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway.; Centre for Cancer Biomarkers CCBIO, University of Bergen, 5009 Bergen, Norway.; Department of Pathology, Haukeland University Hospital, 5021 Bergen, Norway. Tan TZ; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore. Pettersen IKN; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway. Hjellbrekke S; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway. Tusubira D; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway. Engelsen AST; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway.; Centre for Cancer Biomarkers CCBIO, University of Bergen, 5009 Bergen, Norway.; INSERM UMR 1186, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France. Daubon T; University of Bordeaux, CNRS, IBGC, UMR 5095, 33000 Bordeaux, France. Mourier A; University of Bordeaux, CNRS, IBGC, UMR 5095, 33000 Bordeaux, France. Thiery JP; Centre for Cancer Biomarkers CCBIO, University of Bergen, 5009 Bergen, Norway.; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.; Guangzhou Regenerative Medicine and Health, Guangdong Laboratory, Guangzhou 510530, China. Dahl O; Department of Oncology and Medical Physics, Haukeland University Hospital, 5021 Bergen, Norway. LorensJB; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway. Tronstad KJ; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway. Røsland GV; Department of Biomedicine, University of Bergen, 5009 Bergen, Norway.; University of Bordeaux, CNRS, IBGC, UMR 5095, 33000 Bordeaux, France.; Department of Oncology and Medical Physics, Haukeland University Hospital, 5021 Bergen, Norway.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Feb 24; Vol. 13 (5). Date of Electronic Publication: 2021 Feb 24.
AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction.
Autorzy:
Landolt L; Department of Clinical Medicine, University of Bergen, Bergen, Norway. Furriol J; Department of Medicine, Haukeland University Hospital, Bergen, Norway. Babickova J; Department of Clinical Medicine, University of Bergen, Bergen, Norway. Ahmed L; BerGenBio ASA, Bergen, Norway. Eikrem Ø; Department of Clinical Medicine, University of Bergen, Bergen, Norway. Skogstrand T; Department of Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Biomedicine, University of Bergen, Bergen, Norway. Scherer A; Spheromics, Kontiolahti, Finland.; Institute for Molecular Medicine Finland FIMM, HiLIFE, University of Helsinki, Helsinki, Finland. Suliman S; Department of Clinical Dentistry, Center for Clinical Dental Research, University of Bergen, Bergen, Norway. Leh S; Department of Clinical Medicine, University of Bergen, Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway. LorensJB; Department of Biomedicine, Center for Cancer Biomarkers, University of Bergen, Bergen, Norway. Gausdal G; BerGenBio ASA, Bergen, Norway. Marti HP; Department of Clinical Medicine, University of Bergen, Bergen, Norway.; Department of Medicine, Haukeland University Hospital, Bergen, Norway. Osman T; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
